Medicine & Life Sciences
Major Depressive Disorder
100%
Antidepressive Agents
97%
Ketamine
95%
Glutamic Acid
48%
Treatment-Resistant Depressive Disorder
31%
Glutamate Receptors
29%
Diazoxide
27%
Depression
25%
Potassium Channels
23%
Bipolar Disorder
20%
Mood Disorders
19%
gamma-Aminobutyric Acid
19%
N-Methyl-D-Aspartate Receptors
19%
Clinical Trials
17%
2-chloro-4-(1-(4-fluorophenyl)-2,5-dimethyl-1H-imidazol-4-ylethynyl)pyridine
17%
traxoprodil mesylate
15%
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid
13%
Biomarkers
13%
Cytokines
12%
Hydroxyl Radical
11%
N-Methylaspartate
11%
Insulin Resistance
11%
Glycine
11%
Placebos
10%
Brain
9%
Neuronal Plasticity
9%
Synaptic Transmission
9%
Neurotransmitter Agents
9%
Therapeutics
9%
National Institute of Mental Health (U.S.)
9%
Drug Receptors
9%
AZD2066
9%
Neuroimaging
9%
Norepinephrine
9%
4-methylbenzyl 3-fluoro-4-((pyrimidin-2-ylamino)methyl)piperidine-1-carboxylate
8%
Magnetoencephalography
8%
KATP Channels
8%
AZD6765
8%
Metabotropic Glutamate Receptors
8%
Acids
8%
Central Nervous System
8%
Kainic Acid
7%
Proton Magnetic Resonance Spectroscopy
7%
Brain-Derived Neurotrophic Factor
7%
Aspartic Acid
7%
metabotropic glutamate receptor 7
6%
metabotropic glutamate receptor 4
6%
Drug Delivery Systems
6%
metabotropic glutamate receptor 2
6%
NR2B NMDA receptor
6%